These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 4998693

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
    He S, Grasing K.
    Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic analysis of the hypothermic responses of the morphine-dependent rhesus monkey.
    Holtzman SG, Villarreal JE.
    J Pharmacol Exp Ther; 1971 May; 177(2):317-25. PubMed ID: 4998695
    [No Abstract] [Full Text] [Related]

  • 27. The effects of naloxone and nalorphine during the development of morphine dependence in rhesus monkeys.
    Aceto MD, Flora RE, Harris LS.
    Pharmacology; 1977 May; 15(1):1-9. PubMed ID: 402658
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Psychological approaches to opiate dependence and self-administration by laboratory animals.
    Schuster CR.
    Fed Proc; 1970 May; 29(1):2-5. PubMed ID: 4983813
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
    Wikler A.
    Adv Biochem Psychopharmacol; 1973 May; 8(0):399-414. PubMed ID: 4795072
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.